Financial Reports Latest Updates Industry Maps Economic Calendar

Outset Medical, Inc. (OM) Annual Reports

Q: Where can I read Outset Medical, Inc. (OM) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Outset Medical, Inc. is listed on Nasdaq, classified by the SEC under Electromedical & Electrotherapeutic Apparatus (SIC 3845). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1484612 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$31.6M	$31.4M	+0.7%
Operating income	$-15.7M	$-16.9M	+7.1%
Net income	$-18.0M	$-18.5M	+3.0%
EPS (diluted)	$-0.97	$-1.04	+6.7%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 31.6 mn Net income -18.0 mn

Show table：Income statement

Item	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	2.01	2.49	2.87	2.63	7.09	7.19	11.7	13.8	17.3	22.9	25.2	26.3	28.1	30.6	25.1	27.8	32.0	33.5	36.0	30.4	30.5	28.2	27.4	28.7	29.5	29.8	31.4	29.4	28.9	27.9	31.6
Gross profit	-6.11	-5.26	-4.47	-5.29	-2.78	-3.56	-4.76	-5.13	0.42	0.29	1.05	2.95	3.32	4.44	3.78	4.34	5.27	6.43	7.70	7.16	7.71	8.22	9.78	9.82	10.8	11.1	11.9	11.6	12.2	12.1	13.3
Operating income	-46.6	—	—	-18.4	-18.6	-20.2	-24.9	-40.7	-31.6	-29.7	-29.9	-30.1	-40.8	-36.5	-43.7	-41.0	-39.8	-43.5	-43.5	-45.5	-37.4	-36.9	-30.8	-23.8	-21.9	-16.4	-16.9	-15.8	-17.6	-16.9	-15.7
Net income	-49.8	-16.4	-17.0	-15.4	-19.4	-20.6	-26.5	-42.3	-32.0	-30.0	-30.2	-30.5	-41.2	-36.9	-43.8	-40.8	-41.4	-44.0	-44.0	-46.2	-38.6	-39.9	-34.5	-27.9	-25.6	-25.8	-18.5	-17.8	-19.5	-19.0	-18.0

Balance sheet

Quarterly · In mn (USD)

Total assets 242 mn Total liabilities 146 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	—	79.7	—	—	368	346	322	448	433	410	377	346	310	374	337	309	284	291	325	295	275	258	287	276	265	251	237	228
Total assets	—	—	—	—	88.4	—	—	426	404	380	505	489	463	432	401	366	400	363	334	308	314	346	315	293	276	301	289	277	265	249	242
Current liabilities	—	—	—	—	24.9	—	—	33.0	36.7	34.8	35.4	41.4	51.7	48.9	55.2	49.6	52.0	44.3	48.8	53.0	55.3	50.7	43.4	42.4	45.4	34.2	36.9	37.5	37.6	37.6	43.9
Total liabilities	—	—	—	—	51.1	—	—	71.7	75.2	73.2	73.7	79.0	89.4	86.3	91.5	86.6	154	146	151	155	191	253	246	245	249	131	134	135	138	138	146
Equity	-288	-312	-336	-353	-372	-308	-334	354	329	307	431	410	374	345	310	279	246	216	183	152	123	93.2	68.6	47.8	26.8	170	155	142	127	112	96.3

Cash flow

Quarterly · In mn (USD)

Operating -9.63 mn Investing 14.2 mn Financing -0.09 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-46.4	—	—	-55.1	-15.2	-24.9	-19.2	-29.1	-25.8	-38.6	-30.8	-28.1	-32.7	-38.3	-38.6	-34.3	-34.5	-44.8	-28.2	-34.0	-24.4	-45.9	-33.3	-20.6	-16.5	-25.7	-4.82	-6.32	-9.52	-12.8	-9.63
Investing	-68.8	—	—	61.5	12.8	19.2	6.31	-31.9	10.4	-6.81	-97.5	-21.8	-16.4	-33.4	-1.32	20.2	-51.8	2.64	27.1	29.8	23.4	-59.0	38.9	15.9	108	-78.1	-31.2	2.97	8.59	7.90	14.2
Financing	135	—	—	0.14	0.11	127	0.03	260	-0.87	2.22	151	6.19	0.93	3.72	1.04	2.53	65.6	5.28	1.04	4.10	33.2	68.6	0.08	0.12	-0.94	55.7	-0.38	0.23	0	0.5	-0.09
Cash at period end	—	—	—	39.2	36.9	158	142	311	295	252	274	231	182	114	75.5	63.9	73.2	36.4	36.4	36.3	68.5	32.2	37.9	33.3	124	75.9	39.6	36.4	35.0	30.6	35.0

Profitability

Quarterly · %

Gross margin 42.0% Operating margin -49.5% Net margin -56.9%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	-304.7%	-211.1%	-155.6%	-201.3%	-39.2%	-49.6%	-40.6%	-37.3%	2.4%	1.3%	4.2%	11.2%	11.8%	14.5%	15.1%	15.6%	16.5%	19.2%	21.4%	23.6%	25.3%	29.2%	35.7%	34.3%	36.5%	37.2%	37.8%	39.4%	42.4%	43.4%	42.0%
Operating margin	-2320.0%	—	—	-701.5%	-262.1%	-281.1%	-212.1%	-296.1%	-183.3%	-129.5%	-118.6%	-114.5%	-144.9%	-119.4%	-174.5%	-147.7%	-124.4%	-129.9%	-120.6%	-149.7%	-122.4%	-131.0%	-112.3%	-83.2%	-74.2%	-55.1%	-53.7%	-53.7%	-61.0%	-60.7%	-49.5%
Net margin	-2480.3%	-659.3%	-592.9%	-585.6%	-274.5%	-287.2%	-225.7%	-307.5%	-185.8%	-131.0%	-119.8%	-115.8%	-146.5%	-120.8%	-175.0%	-146.9%	-129.5%	-131.4%	-122.2%	-152.1%	-126.5%	-141.8%	-125.8%	-97.5%	-87.0%	-86.7%	-59.0%	-60.6%	-67.5%	-68.1%	-56.9%

Returns & leverage

Quarterly · %

ROE -59.2% ROA -28.0% Debt ratio 60.3%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	—	—	-17353.8%	—	—	-277.2%	-32.1%	-37.5%	-42.6%	-41.1%	-47.3%	-52.6%	-60.5%	-69.1%	-81.5%	-93.7%	-109.1%	-126.5%	-141.0%	-171.0%	-86.5%	-87.7%	-92.3%	-106.2%	-53.2%	-59.2%
ROA	—	—	—	—	-77.3%	—	—	-25.6%	-49.4%	-34.5%	-26.7%	-26.8%	-30.4%	-34.2%	-33.6%	-38.1%	-37.7%	-42.8%	-46.3%	-52.2%	-48.4%	-47.6%	-49.1%	-46.9%	-43.4%	-35.2%	-32.5%	-30.8%	-30.2%	-27.2%	-28.0%
Debt ratio	—	—	—	—	57.8%	—	—	16.8%	18.6%	19.3%	14.6%	16.2%	19.3%	20.0%	22.8%	23.7%	38.5%	40.4%	45.3%	50.6%	60.8%	73.1%	78.2%	83.7%	90.3%	43.6%	46.4%	48.6%	52.0%	55.2%	60.3%

EPS

Quarterly · US$

EPS US$-0.97

Show table：EPS

Item	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	0.74	-4.58	-3.44	-0.75	-0.70	-0.66	-0.65	-0.93	-0.78	-0.92	-0.85	-0.84	-0.90	-0.90	-0.93	-0.76	-0.78	-0.66	-0.55	-0.48	-3.66	-1.04	-1.00	-1.00	-1.03	-0.97

Revenue & profit

Year-to-date · In mn (USD)

Revenue 59.5 mn Net income -37.0 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 242 mn Total liabilities 146 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -22.5 mn Investing 22.1 mn Financing 0.41 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 42.6% Operating margin -54.8% Net margin -62.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -59.2% ROA -28.0% Debt ratio 60.3%

EPS

Year-to-date · US$

EPS US$-2.00

Revenue & profit

Annual · In mn (USD)

Revenue 119 mn Net income -81.7 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2019	2020	2021	2022	2023	2024	2025
Revenue	15.1	49.9	103	115	130	114	119
Gross profit	-17.8	-13.0	7.61	17.8	29.0	38.6	46.8
Operating income	—	-117	-131	-161	-170	-113	-66.7
Net income	-68.3	-121	-132	-163	-173	-128	-81.7

Balance sheet

Annual · In mn (USD)

Total assets 265 mn Total liabilities 138 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2019	2020	2021	2022	2023	2024	2025
Current assets	79.7	346	410	374	291	258	251
Total assets	88.4	404	463	400	314	276	265
Current liabilities	24.9	36.7	51.7	52.0	55.3	45.4	37.6
Total liabilities	51.1	75.2	89.4	154	191	249	138
Equity	-372	329	374	246	123	26.8	127

Cash flow

Annual · In mn (USD)

Operating -46.3 mn Investing -97.7 mn Financing 55.5 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2019	2020	2021	2022	2023	2024	2025
Operating	—	-99.0	-130	-146	-131	-116	-46.3
Investing	—	3.95	-143	-66.3	83.0	104	-97.7
Financing	—	386	160	72.9	43.6	67.9	55.5
Cash at period end	36.9	295	182	73.2	68.5	124	35.0

Profitability

Annual · %

Gross margin 39.1% Operating margin -55.8% Net margin -68.3%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2019	2020	2021	2022	2023	2024	2025
Gross margin	-118.1%	-26.1%	7.4%	15.5%	22.2%	33.9%	39.1%
Operating margin	—	-235.2%	-127.2%	-139.6%	-130.2%	-99.7%	-55.8%
Net margin	-453.0%	-243.3%	-128.6%	-141.2%	-132.5%	-112.6%	-68.3%

Returns & leverage

Annual · %

ROE -106.2% ROA -30.2% Debt ratio 52.0%

Show table：Returns & leverage

Item	2019	2020	2021	2022	2023	2024	2025
ROE	—	—	-37.5%	-52.6%	-93.7%	-171.0%	-106.2%
ROA	-77.3%	-49.4%	-30.4%	-37.7%	-48.4%	-43.4%	-30.2%
Debt ratio	57.8%	18.6%	19.3%	38.5%	60.8%	90.3%	52.0%

EPS

Annual · US$

EPS US$-6.70

Show table：EPS

Item	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	-8.03	-2.94	-3.39	-3.49	-2.47	-6.70

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Outset Medical, Inc. (OM) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.